SPARC gets second CRL tied to Sun Pharma's troubled Halol plant
admin 22nd May 2017 Uncategorised 0The manufacturing problems at Sun Pharma’s key Halol, India, plant have taken the spark out of its drug development arm SPARC. For the second time, the FDA has stymied approval of a new drug from Sun’s novel drug development group because of problems at the plant.
More: SPARC gets second CRL tied to Sun Pharma's troubled Halol plant
Source: fierce